Multiple myeloma accounts for only 1.8% of cancers, but it is the second-most common blood cancer, with approximately 36,000 ...

Idvynso uniquely offers a two-drug, tenofovir-free, non-INSTI single-tablet regimen intended for switch in stable, suppressed ...

See how 2026 ADA guidance broadens CGM use beyond insulin, urges payer coverage, and highlights kids, pregnancy, and older ...

A study in JAMA Dermatology found that people using an AI tool were more accurate and confident in identifying skin ...

A new AI-enabled “Digital Front Door” is intended to match patients to the right site of care pre-arrival, potentially ...

Optum Health posted $1.3B adjusted earnings and cited dual-eligible value-based care associations with fewer admissions and ...

ILD was detected in about half of AAV cases, and one-third had fibrotic ILD, indicating a substantial pulmonary fibrosis ...

The shift from acute to chronic low back pain is driven by a mix of clinical, psychological, inflammatory and social factors, ...

Diagnostic delay was common (277/505) and operationalized as ≥1 inpatient or ≥2 outpatient diagnoses for key ATTR-CM ...

With Helio Liver, patients can have the blood test done right in the office, which is much more convenient. This convenience ...

In this episode, Long-Term Repigmentation Outcomes and Real-World Use of Ruxolitinib Cream, Dr. Desai explores the following ...

Cancer therapeutics and orphan drugs are no longer niche areas. Specialty drugs are now a significant portion of the ...